Impedance Pneumography in Assessment of Asthma Control in Preschool Children
NCT ID: NCT03377192
Last Updated: 2020-02-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
53 participants
OBSERVATIONAL
2017-11-28
2020-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Longitudinal Assessment of Children With Severe Asthma and Severe Pre-school Wheeze
NCT01982162
Evaluation of a Remote Asthma Monitoring Program to Improve Health Outcomes in Pediatric Asthma
NCT05139485
Remote Use of the Asthma Control Test (ACT) to Improve Care of Children With Asthma
NCT03036982
Association Between Activity and PROMIS Pediatric Measures in Children With Asthma
NCT03933540
Small Airway Inflammation and Dysfunction in Different Asthma Phenotypes
NCT03718793
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Impedance pneumography (IP) is a method for measuring changes in the thoracic electrical impedance through skin electrodes, which varies as a function of lung aeration i.e. breathing. Recent technical advancements have enabled IP to be used for accurate non-invasive tidal flow signal measurement. Moreover, in overnight recordings at home, IP was found feasible for quantifying nocturnal TBFV variability in young children with lower respiratory symptoms, showing that preschool children with high risk of asthma present with increased variation of tidal flow profile shape, and momentarily lowered chaoticity, compared to children with lower risk of asthma. So far, there are no studies that have addressed the utility of IP to assess asthma control in young children with asthma.
The purpose of this study is to investigate the utility of a commercially available IP device (VENTICA, Icare Finland, Finland) and IP-derived clinical indices in assessing the clinical control of asthmatic children receiving normal therapy in a longitudinal setting. The primary hypothesis is that TBFV variability quantified by IP is associated with disease control during management of young children with asthma. The secondary hypothesis is that TBFV variability quantified by IP predicts changes in disease control during management of young children with asthma.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Attending pediatric ward in the study centre due to asthmatic symptoms (wheeze, cough and/or dyspnea)
* History and clinical signs allowing diagnosis of doctor diagnosed asthma and the need to start regular anti-asthmatic medication
* Signed informed consent
Exclusion Criteria
* Other cardiorespiratory or neurological chronic diseases or states that may affect breathing
* Acute respiratory infection 2 weeks prior to study entry
* Chronic respiratory disorder of prematurity
* Implanted or external active medical devices
4 Years
7 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Revenio Research
INDUSTRY
Mehiläinen
UNKNOWN
HUS Skin and Allergy Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pekka Malmberg, MD, PhD
Head of clinical physiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pekka Malmberg, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
HUS Skin and Allergy Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
HUS Skin and Allergy Hospital
Helsinki, , Finland
Mehiläinen Paediatric Allergy Clinic
Helsinki, , Finland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Burman J, Malmberg LP, Remes S, Jartti T, Pelkonen AS, Makela MJ. Impulse oscillometry and free-running tests for diagnosing asthma and monitoring lung function in young children. Ann Allergy Asthma Immunol. 2021 Sep;127(3):326-333. doi: 10.1016/j.anai.2021.03.030. Epub 2021 Apr 2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VCS-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.